http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109331216-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K2003-325 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K2201-011 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F220-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F2-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K3-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K3-346 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K3-36 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K3-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K3-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K3-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F2-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F222-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F222-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F220-56 |
| filingDate | 2018-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109331216-B |
| titleOfInvention | Quick hemostatic hydrogel and preparation method thereof |
| abstract | The invention discloses a rapid hemostatic hydrogel which comprises acrylamide, inorganic nanoparticles, tannic acid, a cross-linking agent, an initiator and an accelerant, wherein the addition amount of the inorganic nanoparticles is 0.2-10% of the weight of the acrylamide, the addition amount of the tannic acid is 1-20% of the weight of the acrylamide, the addition amount of the cross-linking agent is 0.25-2% of the weight of the acrylamide, the addition amount of the initiator is 0.5-3% of the weight of the acrylamide, and the addition amount of the accelerant is 20-40 mu L per 100g of the acrylamide. The invention has the advantages that: 1. the rapid hemostatic hydrogel with the moist tissue adhesion capability, which is prepared by the invention, can be firmly adhered to body tissues without depending on additional adhesives, bandages and the like during use, can keep good adhesion strength during repeated use, and is easy to peel; 2. the hydrogel hemostatic material has high mechanical strength, the breaking elongation of the hydrogel hemostatic material can reach 2200 percent, the compressive strength is 10.15 +/-0.36 MPa, and the hydrogel hemostatic material can meet the requirements of surgical operations. |
| priorityDate | 2018-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.